Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease

Trial Profile

Multicenter, Double-blind Study of Nitazoxanide Compared to Vancomycin in the Treatment of Clostridium Difficile-associated Disease

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Nitazoxanide (Primary) ; Vancomycin
  • Indications Clostridium infections; Diarrhoea
  • Focus Registrational; Therapeutic Use
  • Sponsors Romark Laboratories
  • Most Recent Events

    • 02 Mar 2009 Status changed from discontinued to completed.
    • 15 Feb 2009 Final results were published in Clinical Infectious Diseases in Feb 2009.
    • 28 Oct 2008 Results were presented at ICAAC/IDSA 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top